Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 08-2015 | 08-2014 | 08-2013 | |
| Sales | 0 | 0 | 2,720 | 2,404 | 5,243 |
| Cost of Goods | N/A | N/A | 5,267 | 3,021 | 6,245 |
| Gross Profit | N/A | N/A | -2,547 | -617 | -1,002 |
| Operating Expenses | 120,831 | 0 | 25,897 | 28,661 | 31,833 |
| Operating Income | -120,831 | N/A | -28,177 | -29,257 | -32,590 |
| Interest Expense | 0 | 0 | 30 | 68 | 46 |
| Other Income | 4,922 | 0 | 52 | 5 | 126 |
| Pre-tax Income | -115,909 | 0 | -28,155 | -29,320 | -32,510 |
| Income Tax | N/A | N/A | 1 | 1 | 1 |
| Net Income Continuous | -115,909 | N/A | -28,156 | -29,321 | -32,511 |
| Net Income | $-115,909 | $N/A | $-28,156 | $-29,321 | $-32,511 |
| EPS Basic Total Ops | -41.23 | N/A | -4.57 | -6.48 | -10.48 |
| EPS Basic Continuous Ops | -41.23 | N/A | -4.57 | -6.48 | -10.49 |
| EPS Diluted Total Ops | -41.23 | N/A | -4.57 | -6.48 | -10.48 |
| EPS Diluted Continuous Ops | -41.23 | N/A | -4.57 | -6.48 | -10.49 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -4.57 | -6.48 | -10.48 |
| EBITDA(a) | $-120,812 | $N/A | $-27,520 | $-27,740 | $-30,678 |